Donna's
Tru Story

Advanced non–small
cell lung cancer

Donna is a real patient.

KEYTRUDA may not work for everyone,
but this is her TRU STORY.

I told the kids
I'm
not gonna
give up.
We need to
stick
together and
go
forward.
 

Donna, on family
and fighting cancer

Donna is a real patient.

KEYTRUDA may not work for everyone,
but this is her TRU STORY.

Scroll down to hear more
about Donna's story
in the words of
the people who lived it.

Family members tell how they came together
to support Donna after her diagnosis.

With kids and grandkids at home and a full-time job at a local hardware store, there was plenty in Donna’s life to keep her busy. As a strong-willed, energetic woman she was definitely up to the task. But finding out she had cancer turned her world upside down.

Scroll down to hear more
about Donna's story
in the words of
the people who lived it.

Diagnosis

The first inkling that something was wrong came when she developed vision problems. They intensified to the point where she was taken to a nearby hospital emergency room. There, doctors discovered a tumor pressing on her optic nerve. It was advanced non–small cell lung cancer that had spread to her brain.

 

Treatment Options

Donna and her husband, Lewis, held a family meeting to talk frankly and honestly about the diagnosis and give their kids a chance to have their questions answered. Then they set out to understand Donna’s treatment options.

 

ON KEYTRUDA

After testing for high levels of a biomarker known as PD-L1, Donna entered a clinical trial for KEYTRUDA. Scans conducted during her treatment showed that the tumors in her lungs were shrinking.

During treatment, doctors also monitored Donna's blood work and found that she had a side effect of KEYTRUDA called hypothyroidism. This means that Donna’s thyroid hormone levels were low and now she takes medication for her thyroid.

Donna's scans continued to show improvement and she remained on KEYTRUDA for 24 months.

Learn about clinical trial data with KEYTRUDA 

Today

Given her nature, it’s not surprising that Donna’s attitude toward life today isn’t much different than it was before her diagnosis. In her own emphatic words: “I have things that I want to do and I’m going to keep doing them!”

Experiences with KEYTRUDA differ among individuals. KEYTRUDA will not work for everyone, and it's important to be informed about possible side effects. Always talk to your doctor or health care team if you have questions about your treatment.

   Learn about side effects
with KEYTRUDA 

Maybe people will draw courage and strength from Donna's story. 

Sharon,
Donna's friend and boss

Family members tell how they came together
to support Donna after her diagnosis.
Sign up for support  Learn More About
Clinical Trial Results
 
 
 

Ask Your Health Care Team if KEYTRUDA® (pembrolizumab) Is Right for You

Ask your health care team if KEYTRUDA is right for you

Want more info about KEYTRUDA?

Sign up for regular updates 

Need help talking to
your doctor?

Download a doctor
discussion guide 

For more information or to sign up over the phone, call 85-KEYTRUDA
(855‑398‑7832)(855-398-7832).


Please scroll for full indication

KEYTRUDA is a prescription medicine used to treat a kind of lung cancer called non–small cell lung cancer (NSCLC). KEYTRUDA may be used alone as your first treatment when your lung cancer has spread (advanced NSCLC) and tests positive for “PD-L1” and your tumor does not have an abnormal “EGFR” or “ALK” gene.

KEYTRUDA may also be used alone for advanced NSCLC if you have tried chemotherapy that contains platinum and it did not work or is no longer working and your lung cancer tests positive for "PD-L1" and, if your tumor has an abnormal “EGFR” or “ALK” gene, you have also received an “EGFR” or “ALK” inhibitor medicine that did not work or is no longer working.

PD-L1 = programmed death ligand 1;
EGFR = epidermal growth factor receptor;
ALK = anaplastic lymphoma kinase.


Ask Your Health Care Team if KEYTRUDA® (pembrolizumab) Is Right for You

Ask your health care team if KEYTRUDA is right for you

Want more info about KEYTRUDA?

Sign up for regular updates 

Need help talking to
your doctor?

Download a doctor
discussion guide 

For more information or to sign up over the phone, call 85-KEYTRUDA (855‑398‑7832)(855-398-7832).

Important Safety Information About KEYTRUDA® (pembrolizumab)

KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.

Call or see your doctor right away if you develop any symptoms of the following problems or these symptoms get worse:

Lung problems (pneumonitis). Symptoms of pneumonitis may include shortness of breath, chest pain, or new or worse cough.

Intestinal problems (colitis) that can lead to tears or holes in your intestine. Signs and symptoms of colitis may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; or severe stomach-area (abdomen) pain or tenderness.

Liver problems (hepatitis). Signs and symptoms of hepatitis may include yellowing of your skin or the whites of your eyes, nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine, feeling less hungry than usual, or bleeding or bruising more easily than normal.

Hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas). Signs and symptoms that your hormone glands are not working properly may include rapid heartbeat, weight loss or weight gain, increased sweating, feeling more hungry or thirsty, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, muscle aches, dizziness or fainting, or headaches that will not go away or unusual headache.

Kidney problems, including nephritis and kidney failure. Signs of kidney problems may include change in the amount or color of your urine.

Skin problems. Signs of skin problems may include rash, itching, blisters, peeling or skin sores, or painful sores or ulcers in your mouth or in your nose, throat, or genital area.

Problems in other organs. Signs of these problems may include changes in eyesight, severe or persistent muscle or joint pains, severe muscle weakness, low red blood cells (anemia), shortness of breath, irregular heartbeat, feeling tired, or chest pain (myocarditis).

Infusion (IV) reactions that can sometimes be severe and life-threatening. Signs and symptoms of infusion reactions may include chills or shaking, shortness of breath or wheezing, itching or rash, flushing, dizziness, fever, or feeling like passing out.

Rejection of a transplanted organ. People who have had an organ transplant may have an increased risk of organ transplant rejection if they are treated with KEYTRUDA.

Getting medical treatment right away may help keep these problems from becoming more serious. Your doctor will check you for these problems during treatment with KEYTRUDA. Your doctor may treat you with corticosteroid or hormone replacement medicines. Your doctor may also need to delay or completely stop treatment with KEYTRUDA if you have severe side effects.

Before you receive KEYTRUDA, tell your doctor if you have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus; have had an organ transplant; have lung or breathing problems; have liver problems; or have any other medical problems.

If you are pregnant or plan to become pregnant, tell your doctor. KEYTRUDA can harm your unborn baby. Females who are able to become pregnant should use an effective method of birth control during treatment and for at least 4 months after the final dose of KEYTRUDA. Tell your doctor right away if you become pregnant during treatment with KEYTRUDA.

If you are breastfeeding or plan to breastfeed, tell your doctor. It is not known if KEYTRUDA passes into your breast milk. Do not breastfeed during treatment with KEYTRUDA and for 4 months after your final dose of KEYTRUDA.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Common side effects of KEYTRUDA include feeling tired, itching, diarrhea, decreased appetite, rash, fever, cough, shortness of breath, pain in muscles, bones or joints, constipation, and nausea.

These are not all the possible side effects of KEYTRUDA. Tell your doctor if you have any side effect that bothers you or that does not go away. For more information, ask your doctor or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please read the accompanying Medication Guide for KEYTRUDA and discuss it with your doctor. The physician Prescribing Information also is available.


E-mail a friend

Share this website about a treatment option for advanced non–small cell lung cancer. No personal information (including e-mail addresses) about you or your friend will be collected from this e-mail notification feature offered by Merck.